Pharmaceuticals News

The pharmaceuticals news email from Wiser has been specifically designed for anyone with an interest in the industry. This includes medical practitioners, investors and those involved in research and development. By its very nature, the pharmaceutical industry is subject to constant change. It is a research-driven industry with companies spending much of their revenues developing new medicines and vaccines. As a result patients are able to get new and more effective treatments. This is helping to increase the life expectancy of individuals in most countries. But there are challenges. The costs of the research and development can be large which puts up the price of drugs, while governments and the medical industry argue to try to keep prices as low as possible. The industry also faces challenges from alternatives, both legal (through generic drugs) and illegal (through black market economies). To follow the latest developments in this industry you should sign up for the pharmaceuticals news email from Wiser. It is the best way to find must-read articles on the topic from around the web.

Recent Pharmaceuticals News Coverage
 
Your Weekly Recommendations Monday, May 29, 2017
 
Recommended for you
CMSC: Chemo Drug Offers Durable Effects in MS (CME/CE)
MedPage Today • Ed Susman
Week In Review: China Life Science Venture Tie-Up: WuXi And Frontline Merge
Seeking Alpha • Chinabio Today
Facebook is making a big push this summer to sell ads to drugmakers
CNBC
GSK among biggest gainers as weak pound lifts FTSE 100
Financial Times
Maryland Enacts Law Barring 'Unconscionable' Drug-Price Increases
The Wall Street Journal • Peter Loftus
Middlemen Are Not Passing On All Drug Discounts Intended For Patients
Forbes • Capital Flows, Contributor
Pharma-Grade Chondroitin Scores for Knee OA (CME/CE)
MedPage Today • Nancy Walsh
California Public Employees Union Pensions are Huge Hypocrites on Drug Prices
Red State • Dan Spencer
Money flow into generic drug makers after comments from FDA's Gottlieb a bit uneven
Seeking Alpha • Douglas W. House
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More
Xconomy • Alex Lash
 
Recommended for You
Health Care Industry, Merck & Co., Inc.
CMSC: Chemo Drug Offers Durable Effects in MS (CME/CE)
MedPage TodayEd Susman
NEW ORLEANS -- Patients with relapsing multiple sclerosis (MS) who were free from disease activity saw continued benefits in clinical and imaging outcomes with long-term use of cladribine tablets, researchers reported here. "Overall rates of new clinical and MRI-detected disease activity-free status...
Share
Cancer, Google Inc
Week In Review: China Life Science Venture Tie-Up: WuXi And Frontline Merge
Seeking AlphaChinabio Today
Deals and Financings Two prominent China-US healthcare investment firms plan to join forces. WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital. Together, the two firms have almost $800 million under management. 6 Dimensions plans to continue growing...
Share
Pharmaceuticals
Facebook is making a big push this summer to sell ads to drugmakers
CNBC
Facebook is hosting an invite-only summit in June to court health industry leaders.
Share
GlaxoSmithKline plc, Health Care Industry
GSK among biggest gainers as weak pound lifts FTSE 100
Financial Times
Power brands in venture with Novartis deliver high sales growth on improving margins
Share
Law, Pharmaceuticals
Maryland Enacts Law Barring 'Unconscionable' Drug-Price Increases
The Wall Street JournalPeter Loftus
Maryland has enacted a law aimed at curbing steep price increases for generic drugs, the first of its kind in the U.S. and a victory for supporters of many bills in state legislatures targeting the high cost of medicine. Maryland Gov. Larry...
Share
Cancer, Pfizer, Inc.
Middlemen Are Not Passing On All Drug Discounts Intended For Patients
ForbesCapital Flows, Contributor
The Future Of Health Insurance Over 400,000 Americans with cancer suffer from a second disease -- "financial toxicity." The symptoms include missed mortgage and rent payments, raided retirement accounts and decisions about whether to take medicines as prescribed or ration them to...
Share
Health Care Industry, Pharmaceuticals
Pharma-Grade Chondroitin Scores for Knee OA (CME/CE)
MedPage TodayNancy Walsh
A pharmaceutical-grade formulation of chondroitin sulfate was superior to placebo and similar in effect to celecoxib for knee osteoarthritis (OA) in a 6-month randomized study. Among 604 patients with knee OA, pain reduction on a 100-mm visual analog scale (VAS) by 6...
Share
AARP, Abbott Laboratories
California Public Employees Union Pensions are Huge Hypocrites on Drug Prices
Red StateDan Spencer
Two huge California public employee union pension programs are trying to eat their cake and profit from it too. They are helping to make a stink out of drug prices, even as those same drug prices are helping to prop up their...
Share
Pharmaceuticals
Money flow into generic drug makers after comments from FDA's Gottlieb a bit uneven
Seeking AlphaDouglas W. House
Some generic drug firms are up in early trading on the heels of comments by FDA Commissioner Scott Gottlieb, M.D. that he wants to accelerate the review of the agency's backlog of 2,640 marketing applications for generic products as a way to...
Share
Cancer, Health Insurance
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More
XconomyAlex Lash
National — Team Trump unveiled its 2018 federal spending proposal—the so-called “skinny budget”—with health and science in the crosshairs. The NIH is looking at a 22 percent cut and the FDA 31 percent, although the administration wants to backfill the FDA loss...
Share